Keratinocyte-specific ablation of the NF-κB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis

被引：0

作者：

Lippens, Saskia ^{[1
]}

Lefebvre, Sylvie ^{[2
]}

Gilbert, Barbara ^{[1
]}

Sze, Mozes ^{[1
]}

Devos, Michael ^{[1
]}

Verhelst, Kelly ^{[1
]}

Vereecke, Lars ^{[1
]}

McGuire, Conor ^{[1
]}

Guerin, Chris ^{[1
]}

Vandenabeele, Peter ^{[1
]}

Pasparakis, Manolis ^{[3
]}

Mikkola, Marja L. ^{[2
]}

Van Loo, Geert ^{[1
]}

Declercq, Wim ^{[1
]}

机构：

[1] VIB UGhent, Ghent, Belgium

[2] Univ Helsinki, Helsinki, Finland

[3] Univ Cologne, Cologne, Germany

来源：

JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2011年 / 131卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：S6 / S6

页数：1

共 27 条

[1] Keratinocyte-specific ablation of the NF-κB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis
Lippens, S.
Lefebvre, S.
Gilbert, B.
Sze, M.
Devos, M.
Verhelst, K.
Vereecke, L.
Mc Guire, C.
Guerin, C.
Vandenabeele, P.
Pasparakis, M.
Mikkola, M. L.
Beyaert, R.
Declercq, W.
van Loo, G.
CELL DEATH AND DIFFERENTIATION, 2011, 18 (12): : 1845 - 1853
[2] Keratinocyte-specific ablation of the NF-κB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis
S Lippens
S Lefebvre
B Gilbert
M Sze
M Devos
K Verhelst
L Vereecke
C Mc Guire
C Guérin
P Vandenabeele
M Pasparakis
M L Mikkola
R Beyaert
W Declercq
G van Loo
Cell Death & Differentiation, 2011, 18 : 1845 - 1853
[3] A20 (TNFAIP3) Alleviates CVB3-Induced Myocarditis via Inhibiting NF-κB Signaling
Gui, Jun
Yue, Yan
Chen, Ruizhen
Xu, Wei
Xiong, Sidong
PLOS ONE, 2012, 7 (09):
[4] The NF-κB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas
Novak, Urban
Rinaldi, Andrea
Kwee, Ivo
Nandula, Subhadra V.
Rancoita, Paola M. V.
Compagno, Mara
Cerri, Michaela
Rossi, Davide
Murty, Vundavalli V.
Zucca, Emanuele
Gaidano, Gianluca
Dalla-Favera, Riccardo
Pasqualucci, Laura
Bhagat, Govind
Bertoni, Francesco
BLOOD, 2009, 113 (20) : 4918 - 4921
[5] A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein
Sakakibara, S.
Espigol-Frigole, G.
Gasperini, P.
Uldrick, T. S.
Yarchoan, R.
Tosato, G.
ONCOGENE, 2013, 32 (10) : 1223 - 1232
[6] A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi’s sarcoma-associated herpesvirus vFLIP oncoprotein
S Sakakibara
G Espigol-Frigole
P Gasperini
T S Uldrick
R Yarchoan
G Tosato
Oncogene, 2013, 32 : 1223 - 1232
[7] A20/TNFAIP3 Discriminates Tumor Necrosis Factor (TNF)-Induced NF-κB from JNK Pathway Activation in Hepatocytes
Pinna, Federico
Bissinger, Michaela
Beuke, Katharina
Huber, Nicolas
Longerich, Thomas
Kummer, Ursula
Schirmacher, Peter
Sahle, Sven
Breuhahn, Kai
FRONTIERS IN PHYSIOLOGY, 2017, 8
[8] The anti-inflammatory protein TNFAIP3/A20 binds the WD40 domain of ATG16L1 to control the autophagic response, NFKB/NF-κB activation and intestinal homeostasis
Serramito-Gomez, Inmaculada
Boada-Romero, Emilio
Slowicka, Karolina
Vereecke, Lars
Van Loo, Geert
Pimentel-Muinos, Felipe X.
AUTOPHAGY, 2019, 15 (09) : 1657 - 1659
[9] TNFAIP3/A20 as a potential regulator of NF-κB-mediated resistance to O6-alkylating chemotherapy in glioblastoma multiforme
Bredel, Markus
Bredel, Claudia
Juric, Dejan
Duran, George
Yu, Ron X.
Harsh, Griffith R.
Vogel, Hannes
Recht, Lawrence D.
Scheck, Adrienne C.
Sikic, Branimir I.
CANCER RESEARCH, 2006, 66 (08)
[10] The NF-κB Negative Regulator TNFAIP3 (A20) is Commonly Inactivated by Somatic Mutations and Genomic Deletions in Marginal Zone B-Cell Lymphomas
Novak, Urban
Rinaldi, Andrea
Kwee, Ivo
Nandula, Subhadra V.
Rancoita, Paola M. V.
Compagno, Mara
Cerri, Michaela
Rossi, Davide
Murty, Vundavalli V.
Zucca, Emanuele
Gaidano, Gianluca
Dalla-Favera, Riccardo
Pasqualucci, Laura
Bertoni, Francesco
Bhagat, Govind
BLOOD, 2008, 112 (11) : 116 - 117

← 1 2 3 →